New and updated preclinical and clinical data presented by biopharma firms at the American Society of Hematology’s annual meeting, Dec. 5-8, including: Company List: Gamida, Glycomimetics, Janssen, Jasper, Kadmon, Keros, Kiadis, Kleo, Maat, Macrogenics, Medigene, Mesoblast, Mustang, Novartis, Oncopeptides, Oncternal, Oryzon, Pfizer, Pharmaessentia, Protagonist, Sangamo, Roche, Rocket, Schrodinger, Seagen, Sierra Oncology, Sumitomo, Sutro, Synthekine, Teneobio, TG, Treadwell, Uniqure, Xencor.